Health3 years ago
QurAlis is preparing for clinical development of its therapeutic candidate QRL-101
(Business Wire) –Qur Alis Corporation, a biotechnology company that develops breakthrough precision medicines for ALS and other genetically validated neurodegenerative diseases, today Cell report Of the...
Recent Comments